These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32101906)

  • 1. Strategies for prediction of drug-resistant pathogens and empiric antibiotic selection in community-acquired pneumonia.
    Gil R; Webb BJ
    Curr Opin Pulm Med; 2020 May; 26(3):249-259. PubMed ID: 32101906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community-acquired pneumonia with risk for drug-resistant pathogens.
    Fleming V; Buck B; Nix N; Kumar P; Southwood R
    South Med J; 2013 Mar; 106(3):209-16. PubMed ID: 23462490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting risk of drug-resistant organisms in pneumonia: moving beyond the HCAP model.
    Webb BJ; Dascomb K; Stenehjem E; Dean N
    Respir Med; 2015 Jan; 109(1):1-10. PubMed ID: 25468412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a Community-Acquired Pneumonia Score To Improve Empiric Antibiotic Selection at an Academic Medical Center.
    Oliver MB; Fong K; Certain L; Spivak ES; Timbrook TT
    Antimicrob Agents Chemother; 2021 Jan; 65(2):. PubMed ID: 33257449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empiric antibiotic selection and risk prediction of drug-resistant pathogens in community-onset pneumonia.
    Webb BJ; Jones B; Dean NC
    Curr Opin Infect Dis; 2016 Apr; 29(2):167-77. PubMed ID: 26886179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia.
    Amati F; Bindo F; Stainer A; Gramegna A; Mantero M; Nigro M; Bussini L; Bartoletti M; Blasi F; Aliberti S
    Adv Respir Med; 2023 May; 91(3):224-238. PubMed ID: 37366804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic Use and Outcomes After Implementation of the Drug Resistance in Pneumonia Score in ED Patients With Community-Onset Pneumonia.
    Webb BJ; Sorensen J; Mecham I; Buckel W; Ooi L; Jephson A; Dean NC
    Chest; 2019 Nov; 156(5):843-851. PubMed ID: 31077649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Empiric therapy of community-acquired pneumonia.
    Green DS; San Pedro GS
    Semin Respir Infect; 2000 Sep; 15(3):227-33. PubMed ID: 11052423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of pneumonia acquired in the community].
    Waschbisch T; Schlesser M; Nati R
    Bull Soc Sci Med Grand Duche Luxemb; 2002; (2):121-34. PubMed ID: 12664656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updates on community acquired pneumonia management in the ICU.
    Nair GB; Niederman MS
    Pharmacol Ther; 2021 Jan; 217():107663. PubMed ID: 32805298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of healthcare-associated pneumonia for empirical antibiotic therapy in the Netherlands.
    Schweitzer VA; van Werkhoven CH; van Heijl I; Smits RF; Boel CHE; Bonten MJM; Postma DF; Oosterheert JJ
    Neth J Med; 2018 Nov; 76(9):389-396. PubMed ID: 30465653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.
    Maruyama T; Fujisawa T; Okuno M; Toyoshima H; Tsutsui K; Maeda H; Yuda H; Yoshida M; Kobayashi H; Taguchi O; Gabazza EC; Takei Y; Miyashita N; Ihara T; Brito V; Niederman MS
    Clin Infect Dis; 2013 Nov; 57(10):1373-83. PubMed ID: 23999080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Community-acquired pneumonia in adults: initial antibiotic therapy.
    King DE; Pippin HJ
    Am Fam Physician; 1997 Aug; 56(2):544-50. PubMed ID: 9262534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Validation of Drug Resistance in Pneumonia (DRIP) Score in Predicting Infections due to Drug-Resistant Pathogens in Community-acquired Pneumonia at Cipto Mangunkusumo Hospital, Jakarta, Indonesia.
    Fadrian F; Chen K; Kumalawati J; Rumende CM; Shatri H; Nelwan EJ
    Acta Med Indones; 2021 Oct; 53(4):416-422. PubMed ID: 35027488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotics for community-acquired pneumonia.
    Dryden M; Hand K; Davey P;
    J Antimicrob Chemother; 2009 Dec; 64(6):1123-5. PubMed ID: 19820250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for the management of community-acquired pneumonia. Current recommendations and antibiotic selection issues.
    Niederman MS
    Med Clin North Am; 2001 Nov; 85(6):1493-509. PubMed ID: 11680113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update in adult community-acquired pneumonia: key points from the new American Thoracic Society/Infectious Diseases Society of America 2019 guideline.
    Metlay JP; Waterer GW
    Curr Opin Pulm Med; 2020 May; 26(3):203-207. PubMed ID: 32084039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current guidelines for the treatment of severe pneumonia and sepsis.
    Bodmann KF
    Chemotherapy; 2005 Aug; 51(5):227-33. PubMed ID: 16103664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New directions in antiinfective therapy for community-acquired pneumonia in the emergency department.
    Moran GJ
    Pharmacotherapy; 2001 Jul; 21(7 Pt 2):95S-99S. PubMed ID: 11446525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and prognostic risk factors of healthcare-associated pneumonia in a Korean tertiary teaching hospital.
    Ahn JH; Lee KH; Chung JH; Shin KC; Lee CK; Kim HJ; Choi EY
    Medicine (Baltimore); 2017 Oct; 96(42):e8243. PubMed ID: 29049213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.